Tag Archives: Treatment

FDA Approves Inrebic (fedratinib) for the Treatment of Patients With Myelofibrosis

FDA Approves Inrebic (fedratinib) for the Treatment of Patients With Myelofibrosis Print this page SUMMIT, N.J.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) today announced the U.S. Food and Drug Administration (FDA) has approved Inrebic (fedratinib) for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.1 “The approval… Read More: FDA Approves Inrebic (fedratinib) for the Treatment of Patients With… »

FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis

FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis Print this page NORTH CHICAGO, Ill., Aug. 16, 2019 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), a 15 mg, once-daily oral… Read More: FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the… »

First Mesothelioma Treatment in 15 Years Approved

May 24, 2019 — The FDA has approved the first new treatment in 15 years for an aggressive form of lung cancer. The device, the NovoTTF-100L System made by Novocure, uses electric fields to stop solid tumors from mesothelioma from dividing. Mesothelioma is a rare but aggressive cancer strongly associated with asbestos exposure. The new… Read More: First Mesothelioma Treatment in 15 Years Approved »

  1. Pages:
  3. 1
  5. 6
  6. 7
  7. 8
  8. 9
  9. 10
  10. 11
  11. 12
  13. 58